130 related articles for article (PubMed ID: 23633493)
1. Regulation of FANCD2 by the mTOR pathway contributes to the resistance of cancer cells to DNA double-strand breaks.
Shen C; Oswald D; Phelps D; Cam H; Pelloski CE; Pang Q; Houghton PJ
Cancer Res; 2013 Jun; 73(11):3393-401. PubMed ID: 23633493
[TBL] [Abstract][Full Text] [Related]
2. Phosphorylation of FANCD2 on two novel sites is required for mitomycin C resistance.
Ho GP; Margossian S; Taniguchi T; D'Andrea AD
Mol Cell Biol; 2006 Sep; 26(18):7005-15. PubMed ID: 16943440
[TBL] [Abstract][Full Text] [Related]
3. Identification of arnicolide C as a novel chemosensitizer to suppress mTOR/E2F1/FANCD2 axis in non-small cell lung cancer.
Chen YF; Pang YC; Wang HC; Wu PE; Chen ZJ; Huang D; Peng DL; Yan YM; Liu C; Wu LC; Fan XZ; Cheng YX; Liu YQ
Br J Pharmacol; 2024 Apr; 181(8):1221-1237. PubMed ID: 37926864
[TBL] [Abstract][Full Text] [Related]
4. The RSF1 histone-remodelling factor facilitates DNA double-strand break repair by recruiting centromeric and Fanconi Anaemia proteins.
Pessina F; Lowndes NF
PLoS Biol; 2014 May; 12(5):e1001856. PubMed ID: 24800743
[TBL] [Abstract][Full Text] [Related]
5. Cooperation of the NEIL3 and Fanconi anemia/BRCA pathways in interstrand crosslink repair.
Li N; Wang J; Wallace SS; Chen J; Zhou J; D'Andrea AD
Nucleic Acids Res; 2020 Apr; 48(6):3014-3028. PubMed ID: 31980815
[TBL] [Abstract][Full Text] [Related]
6. Remodeling of Interstrand Crosslink Proximal Replisomes Is Dependent on ATR, FANCM, and FANCD2.
Huang J; Zhang J; Bellani MA; Pokharel D; Gichimu J; James RC; Gali H; Ling C; Yan Z; Xu D; Chen J; Meetei AR; Li L; Wang W; Seidman MM
Cell Rep; 2019 May; 27(6):1794-1808.e5. PubMed ID: 31067464
[TBL] [Abstract][Full Text] [Related]
7. STIM1 translocation to the nucleus protects cells from DNA damage.
Sanchez-Lopez I; Orantos-Aguilera Y; Pozo-Guisado E; Alvarez-Barrientos A; Lilla S; Zanivan S; Lachaud C; Martin-Romero FJ
Nucleic Acids Res; 2024 Mar; 52(5):2389-2415. PubMed ID: 38224453
[TBL] [Abstract][Full Text] [Related]
8. Mtor-Fanconi Anemia DNA Damage Repair Pathway in Cancer.
Guo F
J Oncobiomarkers; 2014; 2(2):. PubMed ID: 25621286
[TBL] [Abstract][Full Text] [Related]
9. Molecularly targeting the PI3K-Akt-mTOR pathway can sensitize cancer cells to radiotherapy and chemotherapy.
Wang Z; Huang Y; Zhang J
Cell Mol Biol Lett; 2014 Jun; 19(2):233-42. PubMed ID: 24728800
[TBL] [Abstract][Full Text] [Related]
10. mTORC1 and DNA-PKcs as novel molecular determinants of sensitivity to Chk1 inhibition.
Massey AJ; Stephens P; Rawlinson R; McGurk L; Plummer R; Curtin NJ
Mol Oncol; 2016 Jan; 10(1):101-12. PubMed ID: 26471831
[TBL] [Abstract][Full Text] [Related]
11. Regulation of FANCD2 and FANCI monoubiquitination by their interaction and by DNA.
Longerich S; Kwon Y; Tsai MS; Hlaing AS; Kupfer GM; Sung P
Nucleic Acids Res; 2014 May; 42(9):5657-70. PubMed ID: 24623813
[TBL] [Abstract][Full Text] [Related]
12. The genetic and biochemical basis of FANCD2 monoubiquitination.
Rajendra E; Oestergaard VH; Langevin F; Wang M; Dornan GL; Patel KJ; Passmore LA
Mol Cell; 2014 Jun; 54(5):858-69. PubMed ID: 24905007
[TBL] [Abstract][Full Text] [Related]
13. FANCD2 activates transcription of TAp63 and suppresses tumorigenesis.
Park E; Kim H; Kim JM; Primack B; Vidal-Cardenas S; Xu Y; Price BD; Mills AA; D'Andrea AD
Mol Cell; 2013 Jun; 50(6):908-18. PubMed ID: 23806336
[TBL] [Abstract][Full Text] [Related]
14. mTOR Signaling in Growth, Metabolism, and Disease.
Saxton RA; Sabatini DM
Cell; 2017 Mar; 168(6):960-976. PubMed ID: 28283069
[TBL] [Abstract][Full Text] [Related]
15. Genome instability footprint under rapamycin and hydroxyurea treatments.
Li J; Stenberg S; Yue JX; Mikhalev E; Thompson D; Warringer J; Liti G
PLoS Genet; 2023 Nov; 19(11):e1011012. PubMed ID: 37931001
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy and radio-sensitization in H3
Liu C; Kuang S; Wu L; Cheng Q; Gong X; Wu J; Zhang L
CNS Neurosci Ther; 2023 Jul; 29(7):1721-1737. PubMed ID: 37157237
[TBL] [Abstract][Full Text] [Related]
17. ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.
Parvin S; Akter J; Takenobu H; Katai Y; Satoh S; Okada R; Haruta M; Mukae K; Wada T; Ohira M; Ando K; Kamijo T
BMC Cancer; 2023 Apr; 23(1):313. PubMed ID: 37020276
[TBL] [Abstract][Full Text] [Related]
18. OGG1 in the Kidney: Beyond Base Excision Repair.
Zhao F; Zhu J; Shi L; Wu X
Oxid Med Cell Longev; 2022; 2022():5774641. PubMed ID: 36620083
[TBL] [Abstract][Full Text] [Related]
19. Translational Implications for Radiosensitizing Strategies in Rhabdomyosarcoma.
Pomella S; Porrazzo A; Cassandri M; Camero S; Codenotti S; Milazzo L; Vulcano F; Barillari G; Cenci G; Marchese C; Fanzani A; Megiorni F; Rota R; Marampon F
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36362070
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
